Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.6320
-0.0060 (-0.94%)
Oct 16, 2026, 9:52 AM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 27.3 million as of October 15, 2026. It is the 45,724th most valuable company in the world and the 125th biggest in Denmark. Its market cap has decreased by 48.58% in one year.
Market Cap
27.30M
Enterprise Value
26.61M
Revenue
11.52M
Global Rank
Country Rank
#125 Denmark
PE Ratio
n/a
ChartMarket Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 27.30M, a decrease of -91.65%. That is a compound annual growth rate of -32.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 27.30M | -57.30% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.13T |
| Genmab | 145.74B |
| Coloplast | 103.10B |
| Demant | 75.29B |
| Gubra | 4.75B |
| BioPorto | 509.96M |
| Pharma Equity Group | 97.22M |
| ViroGates | 72.86M |